Rare Cancers Special Issue

With an incidence rate of about three cases per million people a year in the United States, Waldenstrom macroglobulinemia is a rare malignancy, and, therefore, has no widely used screening tools. Diagnosing the disease early and, most important, accurately is the art of medicine that remains to be perfected.

Research continues to drive the oncology field.

New clinical trials have oncologists excited about potential new therapies for patients.

This incurable rare cancer of the lymphatic system has seen improvements, but what is the best strategy for treating patients with the disease?

The approach used in discussing palliative care can play a role in whether a patient seeks help.

Clinical trials seek to discover new ways to attack the disease, limit metastasis and prevent recurrence.

Innovations in drug development, surgery, radiation and clinical trials have investigators hard at work in glioblastoma.

Early study results show response to therapy in more than 90 percent of patients.

A recent study found that socioeconomic status can play a role in survival for patients with anal cancer.